<--- Back to Details
First PageDocument Content
Pharmaceutical industry / Food and Drug Administration / Center for Drug Evaluation and Research / United States Department of Health and Human Services / Bioequivalence / Drug development / Generic drug / Pharmaceutical sciences / Pharmacology / Clinical research
Pharmaceutical industry
Food and Drug Administration
Center for Drug Evaluation and Research
United States Department of Health and Human Services
Bioequivalence
Drug development
Generic drug
Pharmaceutical sciences
Pharmacology
Clinical research

Generic Drug User Fee Amendments of 2012 Regulatory Science Initiatives:

Add to Reading List

Source URL: www.fda.gov

Download Document from Source Website

File Size: 34,95 KB

Share Document on Facebook

Similar Documents

International Journal of Drug Development & Research | Oct-Dec 2010 | Vol. 2 | Issue 4 | ISSN | Available online http://www.ijddr.in Covered in Official Product of Elsevier, The Netherlands ©2010 IJDDR

DocID: 1vqle - View Document

International Journal of Drug Development & Research | April-June 2010 | Vol. 2 | Issue 2 | ISSNAvailable online http://www.ijddr.com ©2010 IJDDR Full Length Research Paper

DocID: 1vpvm - View Document

International Journal of Drug Development & Research | April-June 2010 | Vol. 2 | Issue 2 | ISSNAvailable online http://www.ijddr.com ©2010 IJDDR Full Length Research Paper

DocID: 1voF3 - View Document

Seminars on Drug Discovery & Development Wednesdays 17::00, Lecture Hall 1, Pharmazentrum, Klingelbergstrasse 50, Basel Feb 24, 16 Prof. Dr. G. Klebe, Institute of Pharmaceutical Chemistry, Philipps-University Mar

DocID: 1vnYL - View Document

International Journal of Drug Development & Research | April-June 2011 | Vol. 3 | Issue 2 | ISSN | Available online http://www.ijddr.in Covered in Official Product of Elsevier, The Netherlands ©2010 IJDDR

DocID: 1vlGA - View Document